Eli Lilly and QurCan sign genetic medicine deal
Lilly and QurCan Therapeutics have partnered to develop genetic medicine for diseases of the central and peripheral nervous systems.
Read the full article on the original site.
Read Full Article
Read the full article on the original site.
Read Full Article